NCT00291135View on ClinicalTrials.gov

Protocol for Women at Increased Risk of Developing Breast Cancer

PHASE2CompletedINTERVENTIONAL

Enrollment

42

Participants

Timeline

Start Date

January 31, 2003

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2008

Conditions

Breast Cancer

Interventions

DRUG

letrozole

Letrozole 2.5 mg daily

Trial Locations (1)

66160

University of Kansas Medical Center, Kansas City

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Novartis

INDUSTRY

lead

Carol Fabian, MD

OTHER